Mar 06, 2025
Evogene Reports Fourth Quarter and Full Year 2024 Financial Results
Mar 06, 2025
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025
Feb 20, 2025
Evogene Schedules Fourth Quarter 2024 Financial Results Release
Nov 21, 2024
Evogene Reports Third Quarter 2024 Financial Results
Nov 07, 2024
Evogene Schedules Third Quarter 2024 Financial Results Release
Oct 31, 2024
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
Oct 08, 2024
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology
Aug 22, 2024
Evogene Reports Second Quarter 2024 Financial Results
Aug 12, 2024
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
Aug 12, 2024
Evogene Schedules Second Quarter 2024 Financial Results Release
Jul 23, 2024
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split
May 23, 2024
Evogene Reports First Quarter 2024 Financial Results
May 09, 2024
Evogene Schedules First Quarter 2024 Financial Results Release
Mar 20, 2024
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
Mar 07, 2024
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 26, 2024
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
Feb 17, 2021
Evogene Financial Results and Earnings Announcement Schedule for the Fourth Quarter and Full Year of 2020
Jan 05, 2021
Evogene Provides 2020 Year-End Update for CRISPR-IL Consortium
Nov 18, 2020
Evogene Reports Third Quarter 2020 Financial Results
Nov 04, 2020
Evogene Announces Closing of $12 Million Registered Direct Offering